JACoW is a publisher in Geneva, Switzerland that publishes the proceedings of accelerator conferences held around the world by an international collaboration of editors.
@unpublished{liu:cyclotrons2022-webo02,
author = {Liu, Z. Liu},
title = {{Cyclotron-Based Medical Radionuclides and Their Applications in Radiopharmaceuticals}},
% booktitle = {Proc. CYCLOTRONS'22},
booktitle = {Proc. Int. Conf. Cyclotrons Appl. (CYCLOTRONS'22)},
language = {english},
intype = {presented at the},
series = {International Conference on Cyclotrons and their Applications},
number = {23},
venue = {Beijing, China},
publisher = {JACoW Publishing, Geneva, Switzerland},
month = {10},
year = {2023},
note = {presented at CYCLOTRONS'22 in Beijing, China, unpublished},
abstract = {{Liu group is centered on developing radiopharmaceuticals and radiochemical tools for probing and perturbing biological processes in living systems, with a particular focus on cancer. We have developed a series of medical radionuclides with self-developed equipment and purification processes, including Y-86, Zr-89, In-111, Ac-225 , Bi-212, Bi-213, Pb-212 and etc. Our research mainly follows three lines of efforts: 1) Novel in vivo chemistry that enables PET imaging probes for localized protein activation and controlled drug release (Nature 2020; ACS Cent Sci 2022; J Am Chem Soc 2021; Angew Chem 2021); 2) Radiotherapy-activated prodrugs (JACS, 2022; Angew Chem 2022; Angew Chem 2020); 3) Cyclotron production of medical radionuclides, development and translational study of new radiopharmaceuticals for cancer theranostics (Nat Comm 2022; Nat Com 2022; JNM 2022; EJNMMI 2022).}},
}